315 related articles for article (PubMed ID: 19887128)
1. Evaluation of the adjuvant properties of Astragalus membranaceus and Scutellaria baicalensis GEORGI in the immune protection induced by UV-attenuated Toxoplasma gondii in mouse models.
Yang X; Huang S; Chen J; Song N; Wang L; Zhang Z; Deng G; Zheng H; Zhu XQ; Lu F
Vaccine; 2010 Jan; 28(3):737-43. PubMed ID: 19887128
[TBL] [Abstract][Full Text] [Related]
2. Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.
Cong H; Gu QM; Jiang Y; He SY; Zhou HY; Yang TT; Li Y; Zhao QL
Parasite Immunol; 2005; 27(1-2):29-35. PubMed ID: 15813720
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the adjuvant effect of pidotimod on the immune protection induced by UV-attenuated Toxoplasma gondii in mouse models.
Zhao Y; Huang B; Huang S; Zheng H; Li YQ; Lun ZR; Shen J; Wang Y; Kasper LH; Lu F
Parasitol Res; 2013 Sep; 112(9):3151-60. PubMed ID: 23783399
[TBL] [Abstract][Full Text] [Related]
4. Mast cell activator compound 48/40 is not an effective adjuvant for UV-attenuated Toxoplasma gondii vaccine.
Li X; Chen S; Huang S; Lu F
Parasitol Res; 2017 Aug; 116(8):2347-2353. PubMed ID: 28573462
[TBL] [Abstract][Full Text] [Related]
5. Disodium cromoglycate may act as a novel adjuvant for UV-attenuated Toxoplasma gondii vaccine in mouse model.
Li X; Wu Y; Huang S; Lu F
Parasitol Int; 2018 Jun; 67(3):351-356. PubMed ID: 29421521
[TBL] [Abstract][Full Text] [Related]
6. In vitro effects of aqueous extracts of Astragalus membranaceus and Scutellaria baicalensis GEORGI on Toxoplasma gondii.
Yang X; Huang B; Chen J; Huang S; Zheng H; Lun ZR; Shen J; Wang Y; Lu F
Parasitol Res; 2012 Jun; 110(6):2221-7. PubMed ID: 22179265
[TBL] [Abstract][Full Text] [Related]
7. [Cellular immune response in mice vaccinated with uv-attenuated Toxoplasma gondii ZS1 strain trophozoites].
Lu F; Zheng H; Guo H; Chen G
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1999; 17(6):384-6. PubMed ID: 12563744
[TBL] [Abstract][Full Text] [Related]
8. [Oral mixed DNA vaccine protects mice from infection of Toxoplasma gondii].
Cong H; Gu QM; Zhou HY; Guo L; Yang TT; He SY; Li Y; Zhao QL
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2005 Jun; 23(3):159-62. PubMed ID: 16300008
[TBL] [Abstract][Full Text] [Related]
9. [Intranasal immunization with mucosal complex vaccine protects mice against Toxoplasma gondii].
Yin GR; Meng XL; Ma GY; Ma XM
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Aug; 25(4):290-4. PubMed ID: 18038798
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the immune response elicited by multi-antigenic DNA vaccine expressing SAG1, ROP2 and GRA2 against Toxoplasma gondii.
Xue M; He S; Cui Y; Yao Y; Wang H
Parasitol Int; 2008 Dec; 57(4):424-9. PubMed ID: 18562245
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.
Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H
Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice.
Qu D; Wang S; Cai W; Du A
Vaccine; 2008 Aug; 26(35):4541-8. PubMed ID: 18590785
[TBL] [Abstract][Full Text] [Related]
13. Humoral responses and immune protection in mice immunized with irradiated T. gondii tachyzoites and challenged with three genetically distinct strains of T. gondii.
Zorgi NE; Costa A; Galisteo AJ; do Nascimento N; de Andrade HF
Immunol Lett; 2011 Aug; 138(2):187-96. PubMed ID: 21545808
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of immunization with tachyzoite excreted-secreted proteins in a novel susceptible mouse model (A/Sn) for Toxoplasma gondii.
Costa-Silva TA; Meira CS; Ferreira IM; Hiramoto RM; Pereira-Chioccola VL
Exp Parasitol; 2008 Nov; 120(3):227-34. PubMed ID: 18706414
[TBL] [Abstract][Full Text] [Related]
15. Construction and immunogenicity of pseudotype baculovirus expressing Toxoplasma gondii SAG1 protein in BALB/c mice model.
Fang R; Feng H; Nie H; Wang L; Tu P; Song Q; Zhou Y; Zhao J
Vaccine; 2010 Feb; 28(7):1803-7. PubMed ID: 20018269
[TBL] [Abstract][Full Text] [Related]
16. Protective immunity against Toxoplasma challenge in mice by coadministration of T. gondii antigens and Eimeria profilin-like protein as an adjuvant.
Hedhli D; Dimier-Poisson I; Judge JW; Rosenberg B; Mévélec MN
Vaccine; 2009 Apr; 27(16):2274-81. PubMed ID: 19428842
[TBL] [Abstract][Full Text] [Related]
17. IL-15 prolongs the duration of CD8+ T cell-mediated immunity in mice infected with a vaccine strain of Toxoplasma gondii.
Khan IA; Casciotti L
J Immunol; 1999 Oct; 163(8):4503-9. PubMed ID: 10510393
[TBL] [Abstract][Full Text] [Related]
18. Toxoplasma gondii microneme protein 6 (MIC6) is a potential vaccine candidate against toxoplasmosis in mice.
Peng GH; Yuan ZG; Zhou DH; He XH; Liu MM; Yan C; Yin CC; He Y; Lin RQ; Zhu XQ
Vaccine; 2009 Nov; 27(47):6570-4. PubMed ID: 19720368
[TBL] [Abstract][Full Text] [Related]
19. Vaccination of mice with Neospora caninum: response to oral challenge with Toxoplasma gondii oocysts.
Lindsay DS; Lenz SD; Dykstra CC; Blagburn BL; Dubey JP
J Parasitol; 1998 Apr; 84(2):311-5. PubMed ID: 9576504
[TBL] [Abstract][Full Text] [Related]
20. Induction of protective Th1 immune responses in mice by vaccination with recombinant Toxoplasma gondii nucleoside triphosphate hydrolase-II.
Tan F; Hu X; Luo FJ; Pan CW; Chen XG
Vaccine; 2011 Mar; 29(15):2742-8. PubMed ID: 21315696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
